Xinyue Wang
6PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 30, 2024
Mutation-guided chemotherapy-free strategy in first-line immunotherapy for low PD-L1-expressing non-squamous NSCLC.Hui Li, Jingjing Liu, Liang Zhang
|Oct 18, 2024
SMC4 serves as a potential marker for the diagnosis and prognosis of colon adenocarcinoma.Dawei Yang, Wenxin Cheng, Ying Liu
|Oct 17, 2022
The NQO1/p53/SREBP1 axis promotes hepatocellular carcinoma progression and metastasis by regulating Snail stability.Xinyue Wang, Ying Liu, Anna Han
|May 05, 2022
miR-21-5p/Tiam1-mediated glycolysis reprogramming drives breast cancer progression via enhancing PFKL stabilization.Nan Li, Xinyue Wang, Jie Sun
|Jul 26, 2020
Ezrin as a prognostic indicator regulates colon adenocarinoma progression through glycolysis.Yixuan Wang, Yang Yang, Xinyue Wang
|Jul 09, 2020
Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming.Xinyue Wang, Nan Li, Anna Han
Pageof 1
